Immunological analysis of prevention trial with Diamyd® published in peer-reviewed scientific journal

Results of an analysis of a previous prevention trial with Diamyd[®] (GAD-alum) treatment, which indicate a positive and sustained immunomodulating effect after treatment with Diamyd[®] in healthy children at risk for type 1 diabetes, have been published in the scientific journal Journal of Immunology Research.The analysis was carried out by researchers at Lund University and provides additional support for the application of the therapeutic diabetes vaccine Diamyd[®] to prevent or delay clinical type 1 diabetes, and aligns with the rationale of the VINNOVA-financed ASSET project (AI for